Patents by Inventor Erik S. Espling

Erik S. Espling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8383106
    Abstract: Immunoglycoproteins, including antibodies, with improved ADCC and altered glycosylation patterns are provided. Also provided are cell culturing methods and media for producing such immunoglycoproteins, and therapeutic uses of such immunoglycoproteins.
    Type: Grant
    Filed: October 21, 2010
    Date of Patent: February 26, 2013
    Assignee: Emergent Product Development Seattle, LLC
    Inventors: Erik S. Espling, Peter A. Thompson, Peter R. Baum
  • Publication number: 20110256125
    Abstract: Immunoglycoproteins, including antibodies, with improved ADCC and altered glycosylation patterns are provided. Also provided are cell culturing methods and media for producing such immunoglycoproteins, and therapeutic uses of such immunoglycoproteins.
    Type: Application
    Filed: October 21, 2010
    Publication date: October 20, 2011
    Applicant: TRUBION PHARMACEUTICALS, INC.
    Inventors: Erik S. ESPLING, Peter A. THOMPSON, Peter R. BAUM
  • Publication number: 20090041765
    Abstract: Immunoglycoproteins, including antibodies, with improved ADCC and altered glycosylation patterns are provided. Also provided are cell culturing methods and media for producing such immunoglycoproteins, and therapeutic uses of such immunoglycoproteins.
    Type: Application
    Filed: April 11, 2008
    Publication date: February 12, 2009
    Applicant: TRUBION PHARMACEUTICALS, INC.
    Inventors: Erik S. Espling, Peter A. Thompson, Peter R. Baum